Form 4 Filing for ANI Pharmaceuticals Inc.

This filing details a transaction by Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc. On August 25, 2026, Lalwani sold 5,400 shares of Common Stock at a weighted average price of $74.30 per share, as reported in a Rule 10b5-1 trading plan. This transaction resulted in a post-transaction holding of 344,489 shares. The sales were executed across multiple trades with prices ranging from $73.58 to $74.61. The filing was made on August 26, 2026.